7/14/2020 7:39:56 AM
Cytokinetics Agrees To Series Of Transactions With RTW And Ji Xing Related To CK-3773274
5/27/2020 7:37:54 AM
Cytokinetics And ALS Association Announce Continuation Of Their Partnership In The Fight Against ALS
5/8/2020 8:32:40 AM
Amgen And Cytokinetics: FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure
4/14/2020 7:34:56 AM
Cytokinetics Says On Track To Achieve Its Key Strategic Objectives For 2020
2/26/2020 8:31:41 AM
Amgen, Cytokinetics And Servier Report Continuation Of GALACTIC-HF Following Planned Interim Analysis
1/13/2020 7:45:20 AM
Cytokinetics Now Expects Top-line Results From GALACTIC-HF In Q4 2020; Commercial Readiness Underway
1/6/2020 7:36:44 AM
Cytokinetics Says REDWOOD-HCM Has Opened To Enrollment
12/18/2019 7:36:26 AM
Cytokinetics Says FDA Grants Orphan Drug Designation For Reldesemtiv For Amyotrophic Lateral Sclerosis
11/18/2019 9:08:29 AM
Amgen, Cytokinetics And Servier To Present New Results From COSMIC-HF
11/11/2019 9:04:54 AM
Cytokinetics Announces Additional Results From COSMIC-HF
11/8/2019 7:42:02 AM
Cytokinetics Agrees To Sell Aggregate Of $120.0 Mln Of Notes
9/16/2019 7:36:17 AM
Cytokinetics Announces Data From Phase 1 Study Of CK-3773274 At HFSA 23?? Annual Scientific Meeting
8/27/2019 7:35:59 AM
Cytokinetics, Cure SMA Renew Partnership To Advance Awareness Of SMA
7/15/2019 7:38:39 AM
Cytokinetics Completes Patient Enrollment In GALACTIC-HF Phase 3 Event
6/28/2019 7:41:42 AM
Cytokinetics Presents Data From Two Preclinical Studies Of Reldesemtiv
2/21/2019 8:31:31 AM
Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil
1/22/2019 7:31:14 AM
Cytokinetics Announces Receipt Of FDA Feedback Regarding Reldesemtiv In Patients With SMA
12/5/2018 7:32:00 AM
Cytokinetics Reports Initiation Of Phase 1 Clinical Trial Of CK-3773274